MAKEDONIA PALACE HOTEL,
IASIS PHARMA once again expressed its active interest in the field of hypertension, by participating in the 19th Panhellenic Conference for Hypertension. The event took place in 18-20 April 2019, at Makedonia Palace Hotel, Thessaloniki, under the auspices of the Greek Society of Hypertension (E.E.Y).
The Conference was addressed to doctors of all specialties, who deal with the diagnosis and confrontation of hypertensive patients and the prevention of cardiovascular diseases. Over 50 distinguished scientists, both Greek and from abroad, participated as speakers during the three-day event.
IASIS PHARMA, actively interested in hypertension, participated with an exhibition stand, where health experts were given the chance to visit and get informed about the range and the high quality pharmaceutical products that IASIS PHARMA offers at this specific field.
For indication, Rami-Amlo® is a new, patented product of a fixed-dose combination (F.D.C.), that belongs to the pharmaceutical categories of angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers. Each Rami-Amlo® hard capsule consists of one of the following Ramipril/Amlodipine dosages: 5mg/5mg, 5mg/10mg, 10mg/5mg, also in the unique F.D.C. of Ramipril + Amlodipine 10mg/10 mg, thus fully covering all therapeutic needs.
IASIS PHARMA also displayed MAG-IASIS® · its new product, a combination of 1193.57 mg magnesium citrate and 667.56 mg magnesium aspartate dihydrate, equivalent to 243 mg of Magnesium. MAG-IASIS® is produced in Greece, at IASIS PHARMA state-of-the-art effervescent tablets’ manufacturing facility.
Worth to mention is IASIS PHARMA Glucofree® & Glucoplus® launching presentation during the Conference, both having Metformin hydrochloride as their active ingredient. Metformin is being used and has been established for years as the 1st and most important step in pharmaceutically confronting type 2 diabetes.
Glucofree® is produced in 850mg, 60 fc tablets package, and Glucoplus® is produced in 1000mg, 30 fc tablets package.